Folate intake and the risk of prostate cancer: A systematic review and meta-analysis

Prostate Cancer and Prostatic Diseases

Volumn 17, Issue 3, 2014, Pages 213-219

  Tio, M ^a   Andrici, J ^a   Cox, M R ^a   Eslick, G D ^a  

^a NEPEAN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADVANCED CANCER; CANCER LOCALIZATION; CANCER RESEARCH; CANCER RISK; CAUCASIAN; DISEASE ASSOCIATION; FOLIC ACID BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; BLOOD; DIET; DIET SUPPLEMENTATION; MALE; META ANALYSIS; METABOLISM; PROSTATIC NEOPLASMS; RISK;

DIET; DIETARY SUPPLEMENTS; FOLIC ACID; HUMANS; MALE; ODDS RATIO; PROSTATIC NEOPLASMS; RISK;

EID: 84906319786     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2014.16     Document Type: Review

References (52)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin 2011; 61: 69-90.
2. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G et al. Folate deficiency causes uracil misincorporation into human DNA and chromosomal breakage; implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290-3295.
3. Stempak JM, Sohn KY, Chiang EP, Shane B, Kim YI. Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 2005; 26: 981-990.
4. Bistulfi G, Vandette E, Matsui S, Smiraglia DJ. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol 2010; 8: 6.
5. Bistulfi G, Foster BA, Karasik E, Gillard B, Miecznikowski J, Dhiman VK et al. Dietary folate deficiency blocks prostate cancer progression in the TRAMP model. Cancer Prev Res 2011; 4: 1825-1834.
6. Shabbeer S, Williams SA, Simons BW, Herman JG, Carducci MA. Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence. Cancer Prev Res 2012; 5: 229-239.
7. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005; 113: 819-824.
8. Pelucchi C, Galeone C, Talamini R, Negri E, Parpinel M, Franceschi S et al. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev 2005; 14: 944-948.
9. Stevens VL, Rodriguez C, Pavluck Al, McCullough ML, Thun MJ, Calle EE. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006; 163: 989-996.
10. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, Pietinen P, Barrett MJ, Taylor PR et al. Null association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev 2003; 12: 1271-1272.
11. Wien TN, Pike E, Wisloff T, Staff A, Smeland S, Klemp M. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open 2012; 12: e000653.
12. Quin X, Cui Y, Shen L, Sun N, Zhang Y, Li J et al. Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trials. Int J Cancer 2013; 133: 1033-1041.
13. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50000 individuals. Lancet 2013; 381: 1029-1036.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Metaanalysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ 2003; 327: 557-560.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
18. Aune D, Deneo-Pellegrini H, Ronco AL, Boffetta P, Acosta G, Mendilaharsu M et al. Dietary folate intake and the risk of 11 types of cancer: a case control study in Uruguay. Ann Oncol 2011; 22: 444-451.
19. Bassett JK, Severi G, Hodge AM, Baglietto L, Hopper JL, English DR et al. Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality. Cancer Causes Control 2012; 23: 855-863.
20. Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW. Serum levels of folate, lycopene, beta-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 2010; 64: 1235-1238.
21. Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 1632-1642.
22. Jackson MD, Tulloch-Reid MK, McFarlane-Anderson N, Watson A, Seers V, Bennett FI et al. Complex interaction between serum folate levels and genetic polymorphisms in folate pathway genes: biomarkers of prostate cancer aggressiveness. Genes Nutr 2013; 8: 199-207.
23. Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev 2008; 17: 279-285.
24. Kobayashi LC, Limburg H, Miao Q, Woolcott C, Bedard LL, Massey TE et al. Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions. Front Oncol 2012; 2: 100.
25. Lewis JE, Soler-Vila H, Clark PE, Kresty LA, Allen GO, Hu JJ. Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 2009; 61: 216-224.
26. Shannon J, Phoutrides E, Palma A, Farris P, Peters L, Forester A et al. Folate intake and prostate cancer risk: a case-control study. Nutr Cancer 2009; 61: 617-628.
27. Verhage BA, Cremers P, Schouten LJ, Goldbohm RA, van den Brandt PA. Dietary folate and folate vitamers and the risk of prostate cancer in The Netherlands Cohort Study. Cancer Causes Control 2012; 23: 2003-2011.
28. Vidal AC, Grant DJ, Williams CD, Masko E, Allott EH, Shuler K et al. Associations between Intake of Folate, Methionine, and Vitamins B12,B6, and Prostate Cancer Risk in American Veterans. J Cancer Epidemiol 2012; 2012: 957467.
29. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI. Diet and prostate cancer: a casecontrol study. Eur J Cancer 1997; 33: 101-107.
30. Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, Taylor PR, Virtamo J, Albanes D. Dietary factors of one-carbon metabolism and prostate cancer risk. Am J Clin Nutr 2006; 84: 929-935.
31. Roswall N, Larsen SB, Friis S, Outzen M, Olsen A, Christensen J et al. Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. Cancer Causes Control 2013; 24: 1129-1135.
32. deVogel S, Meyer K, Fredriksen A, Ulvik A, Ueland PM, Nygard O et al. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-A Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int J Epidemiol 2013; 42: 201-210.
33. Cai D, Ning L, Pan C, Liu X, Bu R, Chen X et al. Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population. J Genet 2010; 89: 263-267.
34. Collin SM, Metcalf C, Zuccolo L, Lewis SJ, Chen L, Cox A et al. Association of folatepathway gene polymorphisms with the risk of prostate cancer: a populationbased nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2009; 18: 2528-2539.
35. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302: 2119-2126.
36. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS et al. Folic acid and risk of prostate cancer: results from a randomized trial. J Natl Cancer Inst 2009; 101: 432-435.
37. Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D et al. Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial. Stroke 2012; 43: 1572-1577.
38. Kasperzyk JL, Fall K, Mucci LA, Hakansson N, Wolk A, Johansson JE et al. Onecarbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr 2009; 90: 561-569.
39. Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM. Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer 2001; 39: 12-18
40. Rossi E, Hung J, Beilby JP, Knuiman MW, Divitni ML, Bartholomew H. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006; 16: 206-212.
41. Tavani A, Malerba S, Pelucchi C, Dal Maso L, Zuchetto A, Serraino D et al. Dietary folates and cancer risk in a network of case-control studies. Ann Oncol 2012; 23: 2737-2742.
42. Van Guelphen BR, Wiren SM, Bergh AR, Hallmans G, Stattin PE, Hultdin J. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur J Cancer Prev 2006; 15: 46-50.
43. Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control 2009; 20: 691-698.
44. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011; 141: 261-266.
45. Skeie G, Braaten T, Hjartaker A, Lentjes M, Amiano P, Jakszyn P et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eu J Clin Nutr 2009; 63: S226-S238.
46. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American med. J Urol 2007; 177: 444-449.
47. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53: 171-184.
48. Mordukhovich I, Reiter PL, Backes DM, Family L, Mccullough LE, Brien KM et al. A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 2011; 22: 341-357.
49. Appel LJ, Miller 3rd ER, Jee SH, Stolzenberg-Solomon R, Lin PH, Erlinger T et al. Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000; 102: 852-857.
50. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ et al. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine. Am J Clin Nutr 2002; 76: 758-765.
51. Park YJ, Vollset SE, Melse-Boonstra A, Chajes V, Ueland PM, Slimani N. Dietary intake and biological measurement of folate: a qualitative review of validation studies. Mol Nutr Food Res 2013; 57: 562-581.
52. Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr 2011; 94: 666S-672SS.